In Vivo Phenotypic Screens to Identify Novel Therapeutic Targets to Treat Conserved Pathologies in Neurodegenerative Disorders
Time: 11:30 am
day: Conference Day One - Track One
Details:
- Unbiased in vivo phenotypic screens can discover novel therapeutic targets underlying conserved pathological problems in neurodegenerative disorders
- Identifying neuro-protective/-regenerative therapies to preserve spared neuronal populations affected by progressive, chronic neurodegenerative diseases.
- Developing KCC2 neuromodulation therapies for neurodegenerative disorders involving excitation/inhibition imbalance and neuronal circuit disinhibition within the CNS